Special Issue "Feature Papers"
A special issue of Biomedicines (ISSN 2227-9059).
Deadline for manuscript submissions: closed (31 October 2013)
Prof. Dr. Kenneth Cornetta
Department of Medical and Molecular Genetics, Indiana University School of Medicine, USA
Interests: gene therapy; lentiviral vectors; retroviral vectors; safety of gene therapy; vector production and certification
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed Open Access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. For the first couple of issues the Article Processing Charge (APC) will be waived for well-prepared manuscripts. English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.
Biomedicines 2013, 1(1), 3-16; doi:10.3390/biomedicines1010003
Received: 4 November 2013; in revised form: 22 November 2013 / Accepted: 26 November 2013 / Published: 4 December 2013| Download PDF Full-text (448 KB) | Download XML Full-text
Biomedicines 2013, 1(1), 49-78; doi:10.3390/biomedicines1010049
Received: 23 October 2013; in revised form: 10 December 2013 / Accepted: 11 December 2013 / Published: 16 December 2013| Download PDF Full-text (275 KB) | Download XML Full-text
Biomedicines 2014, 2(1), 1-13; doi:10.3390/biomedicines2010001
Received: 19 November 2013; in revised form: 17 January 2014 / Accepted: 17 January 2014 / Published: 24 January 2014| Download PDF Full-text (319 KB) | Download XML Full-text
Biomedicines 2014, 2(1), 14-35; doi:10.3390/biomedicines2010014
Received: 7 November 2013; in revised form: 22 January 2014 / Accepted: 23 January 2014 / Published: 27 January 2014| Download PDF Full-text (342 KB)
Biomedicines 2014, 2(1), 50-79; doi:10.3390/biomedicines2010050
Received: 19 November 2013; in revised form: 10 January 2014 / Accepted: 17 February 2014 / Published: 26 February 2014| Download PDF Full-text (301 KB) | Download XML Full-text
Review: Product-Related Impurities in Clinical-Grade Recombinant AAV Vectors: Characterization and Risk Assessment
Biomedicines 2014, 2(1), 80-97; doi:10.3390/biomedicines2010080
Received: 13 December 2013; in revised form: 20 February 2014 / Accepted: 20 February 2014 / Published: 3 March 2014| Download PDF Full-text (246 KB) | Download XML Full-text
Last update: 4 April 2013